Nov. 28, 2018 Price forecast | 2 weeks: 0.76% | 1 month: 2.18% | 3 months: 4.43%


GKOS stock forecast

Our latest prediction for Glaukos Corp.'s stock price was made on the Nov. 28, 2018 when the stock price was at 62.39$.

In the short term (2weeks), GKOS's stock price should outperform the market by 0.76%. During that period the price should oscillate between -6.43% and +7.03%.

In the medium term (3months), GKOS's stock price should outperform the market by 4.43%. During that period the price should oscillate between -14.08% and +20.00%.

Create a solid portfolio with GKOS

Add GKOS to your portfolio and optimize it!


About Glaukos Corp.

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

At the moment the company generates 181M USD in revenues.

On its last earning announcement, the company reported a loss of -0.37$ per share.

The book value per share is 4.21$

Glaukos Corp. website


Three months stock forecastNov. 28, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
181M 86.20% -13M -7.20% -13M -0.37 - - 35M 4.21 19M -10M 9M